NewsRoom Articles - Page 29 of 214

TuesdaySep 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership

The company is seeking an accelerated approval regulatory pathway for CNM-Au8® for ALS. The FDA agreed to an in-person meeting to reevaluate Clene’s submission. Lead drug candidate CNM-Au8 has been shown to restore and protect neurological function, offering hope for patients with neurodegenerative conditions. The FDA meeting will be held before the end of November and will be attended by top FDA officials and key opinion leaders in ALS, biostatistics and biomarkers. Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including…

MondaySep 23, 2024 10:00 am

Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD Patients

Sleep disorders are often caused by hypermotor restlessness, restless leg syndrome, hyperarousability, periodic limb movements in sleep and restless sleep disorder. Now, a new study has considered the role iron levels play in causing these disorders. Iron is usually found in microglia, oligodendrocytes, astrocytes and neurons. This element is needed to help synthesize neurotransmitters that regulate the wake/sleep cycle. The study used data gathered from structured intake forms and clinical evaluations conducted at the Child & Adolescent Psychiatry division of the Sleep/Wake-Behavior clinic in BC Children’s Hospital. Data on parental history of iron deficiency, recent iron status and covariate factors…

FridaySep 20, 2024 10:00 am

Women Reach Settlement After Yale Nurse Switched Painkillers with Saline Solution

Last week, a group of women who experienced severe pain at a fertility clinic at Yale University after they received saline instead of a painkiller had their suits against the Ivy League school settled. This settlement comes after seven women sued the institution in 2021. Soon after, more patients filed lawsuits, which brought the number of plaintiffs to more than 150. Most of them claimed that because of their experience at the clinic, they suffered from post-traumatic stress disorder (PTSD). One of the plaintiffs, Soryorelis Henry, stated that the experience, which should have been joyous and hopeful, became traumatic. Collectively,…

ThursdaySep 19, 2024 11:45 am

Astiva Health Enhances Medicare Open Enrollment with Tailored Care and Comprehensive Benefits

Open enrollment provides people with Medicare an opportunity to review options, make changes to coverage. Evaluating network, extra benefits can help individuals make important plan decisions. Astiva Health provides a wide range of valuable extra benefits, leading the industry with its generous grocery allowance and rebate programs, along with transportation services, fitness programs, vision and hearing care, and more. As Medicare open enrollment approaches, eligible individuals have the chance to review their healthcare options and make important decisions about their coverage. Astiva Health, a leading Medicare Advantage Prescription Drug (“MAPD”) health plan, stands out with its extensive network in Southern…

WednesdaySep 18, 2024 10:00 am

Biden Admin to Pass Rules Changing Duty-Free Shipping by eCommerce Businesses

Last week, the White House announced its plans to alter trade rules it claimed had been flouted by China-founded e-commerce sites. In a fact sheet, the Biden administration revealed that its proposed regulations targeted the de minimis exception, which permitted imported products to enter the United States without taxes or duties if the aggregate fair retail price of the shipment was $800 or less. The exemption threshold was raised from $200 in 2015 to $800 to help small businesses, including sellers on e-commerce sites such as eBay. The fact sheet noted that total shipments that claimed this exemption during the…

MondaySep 16, 2024 10:00 am

Detailed Data Could Save Customers Billions in FSA Funds for Healthcare

It is estimated that every year, $4 billion is lost from flexible spending accounts when the “use it or lose it” feature goes into effect. This is something that affects both consumers and the healthcare industry, with patients rushing to determine what is eligible as they work to allocate their monies to pay for healthcare expenses. In addition to the last-minute rush, the confusion also increases at the register, where patients must ensure their healthcare spending is well allocated between their credit and debit cards and their flexible spending accounts. In a recent interview, Alpesh Chokshi of Banyan revealed that…

FridaySep 13, 2024 10:00 am

WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development

A recently conducted review has determined that there’s no correlation between the use of mobile phones and a heightened risk of acoustic neuromas, meningiomas and gliomas. The review also found no correlation between mobile phone use and leukemia or salivary and pituitary cancers. Mobile phones are low-powered transmitters of radiofrequency-electromagnetic fields. They work by transmitting radio waves to their destinations via cell towers. The review included 63 studies conducted between 1994 and 2022 and published in more than 20 countries. Each study examined how exposure to radio frequency-electromagnetic fields transmitted by electronic devices, primarily mobile phones, affected the health of…

WednesdaySep 11, 2024 10:00 am

Does Multiple Sclerosis Reduce Risk of Developing Dementia?

Multiple sclerosis is a chronic illness of the central nervous system that affects an individual’s immune system, causing it to attack the body by mistake. On the other hand, Alzheimer’s is a neurodegenerative illness that affects an individual’s memory as well as cognitive function. Now, a new study has found that patients with multiple sclerosis are less likely to present with molecular signs of Alzheimer’s, suggesting a protective component that could help develop new treatments. The study was carried out by researchers at the Washington University School of Medicine in St. Louis. It was based on an idea of Dr.…

WednesdaySep 11, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Management Presenting Recent Achievements, CNM-Au8(R) Results, at H.C. Wainwright Conference

The H.C. Wainwright 26th Annual Global Investment Conference is being held on-line and in person, Sept. 9-11. Clene management will give a virtual presentation of the company’s most recent achievements and results and will hold one-on-one investor meetings. Lead drug candidate CNM-Au8 has been shown to restore and protect neurological function, offering new hope for patients with neurodegenerative conditions. The company is seeking FDA approval to file a new drug application for CNM-Au8, using the accelerated approval pathway for treatment of ALS. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to…

MondaySep 09, 2024 10:00 am

Frailty Trajectories Unaffected by Enrollment in Medicare Advantage

Medicare Advantage (MA) has become popular in recent years, with 2023 figures showing that the plans have more than 29 million enrollees. This figure represents 51% of all beneficiaries under Medicare. Plans under Medicare Advantage have lower premiums while covering additional benefits such as dental and vision. However, enrollees have access to a limited network of practitioners in comparison to enrollees of conventional Medicare. Additionally, beneficiaries of Medicare Advantage differ from beneficiaries of traditional Medicare across both socioeconomic and health status, with enrollees of the former plans being more likely to have lower incomes and be Hispanic or Black. Now,…